Compared to Estimates, Intuitive Surgical (ISRG) Q3 Earnings: A Look at Key Metrics
Werte in diesem Artikel
For the quarter ended September 2024, Intuitive Surgical, Inc. (ISRG) reported revenue of $2.04 billion, up 16.9% over the same period last year. EPS came in at $1.84, compared to $1.46 in the year-ago quarter.The reported revenue represents a surprise of +1.17% over the Zacks Consensus Estimate of $2.01 billion. With the consensus EPS estimate being $1.65, the EPS surprise was +11.52%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Intuitive Surgical performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Total System Units Placed - Total Company: 379 versus 316 estimated by five analysts on average. Da Vinci Surgical System Installed Base: 9,539 versus 9,498 estimated by four analysts on average. Total System Units Placed - United States: 219 versus 160 estimated by two analysts on average. Revenue- Product (Instruments and accessories and Systems): $1.71 billion versus $1.66 billion estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +17.8% change. Revenue- Services: $328.90 million compared to the $332.31 million average estimate based on seven analysts. The reported number represents a change of +12.3% year over year. Revenue- Systems: $445 million versus $417.75 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +17.3% change. Revenue- Instruments and accessories: $1.26 billion compared to the $1.24 billion average estimate based on seven analysts. The reported number represents a change of +18% year over year. Gross profit- Service: $220.10 million versus $225.36 million estimated by two analysts on average. Gross profit- Product: $1.15 billion versus the two-analyst average estimate of $1.10 billion. View all Key Company Metrics for Intuitive Surgical here>>>Shares of Intuitive Surgical have returned -3.3% over the past month versus the Zacks S&P 500 composite's +3.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.7% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intuitive Surgical, Inc. (ISRG): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Intuitive Surgical
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Intuitive Surgical
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Intuitive Surgical Inc
Analysen zu Intuitive Surgical Inc
Datum | Rating | Analyst | |
---|---|---|---|
19.07.2019 | Intuitive Surgical Buy | Canaccord Adams | |
22.04.2019 | Intuitive Surgical Buy | Canaccord Adams | |
02.04.2019 | Intuitive Surgical Buy | Deutsche Bank AG | |
19.10.2018 | Intuitive Surgical Buy | Canaccord Adams | |
18.04.2018 | Intuitive Surgical Buy | Canaccord Adams |
Datum | Rating | Analyst | |
---|---|---|---|
19.07.2019 | Intuitive Surgical Buy | Canaccord Adams | |
22.04.2019 | Intuitive Surgical Buy | Canaccord Adams | |
02.04.2019 | Intuitive Surgical Buy | Deutsche Bank AG | |
19.10.2018 | Intuitive Surgical Buy | Canaccord Adams | |
18.04.2018 | Intuitive Surgical Buy | Canaccord Adams |
Datum | Rating | Analyst | |
---|---|---|---|
26.01.2018 | Intuitive Surgical Hold | Canaccord Adams | |
18.07.2017 | Intuitive Surgical Sector Perform | RBC Capital Markets | |
30.06.2017 | Intuitive Surgical Neutral | Cantor Fitzgerald | |
30.05.2017 | Intuitive Surgical Hold | Canaccord Adams | |
17.04.2017 | Intuitive Surgical Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
23.01.2015 | Intuitive Surgical Sell | CRT Capital | |
22.10.2014 | Intuitive Surgical Sell | CRT Capital | |
09.01.2009 | Intuitive Surgical Downgrade | Brean Murray, Carret & Co., LLC | |
26.08.2005 | Update Intuitive Surgical Inc. : Underperform | Jefferies & Co |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Intuitive Surgical Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen